Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)

@article{Mouffouk2020FlavonolsAP,
  title={Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)},
  author={Chaima Mouffouk and Soumia Mouffouk and Sara Mouffouk and L. Hambaba and Hamada Haba},
  journal={European Journal of Pharmacology},
  year={2020},
  volume={891},
  pages={173759 - 173759}
}
The novel coronavirus outbreak (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the actual greatest global public health crisis. The lack of efficacious drugs and vaccines against this viral infection created a challenge for scientific researchers in order to find effective solutions. One of the promising therapeutic approaches is the search for bioactive molecules with few side effects that display antiviral properties in natural sources like… Expand

Figures from this paper

Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication
SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
Estrogen Receptor Modulators in Viral Infections Such as SARS−CoV−2: Therapeutic Consequences
An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19

References

SHOWING 1-10 OF 306 REFERENCES
...
1
2
3
4
5
...